Aigen Investment Management, LP Annexon, Inc. Transaction History
Aigen Investment Management, LP
- $487 Million
- Q3 2024
A detailed history of Aigen Investment Management, LP transactions in Annexon, Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 10,048 shares of ANNX stock, worth $53,053. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,048
Previous 17,782
43.49%
Holding current value
$53,053
Previous $87,000
32.18%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ANNX
# of Institutions
146Shares Held
102MCall Options Held
178KPut Options Held
159K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$44.6 Million8.98% of portfolio
-
Satter Management Co., L.P.7.41MShares$39.1 Million76.44% of portfolio
-
Bvf Inc San Francisco, CA7MShares$37 Million1.32% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$34.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$33.9 Million2.49% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $251M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...